SCM
STLN

Sterling Capital Management’s Starling Oncology STLN Stock Holding History

Sterling Capital Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
567
+49
+9% +$206 ﹤0.01% 2860
2026
Q1 		$1.59K Buy
518
+128
+33% +$392 ﹤0.01% 3031
2025
Q4 		$1.39K Buy
390
+245
+169% +$909 ﹤0.01% 3110
2025
Q3 		$506 Buy
145
+2
+1% +$7 ﹤0.01% 3158
2025
Q2 		$293 Buy
+143
New +$358 ﹤0.01% 3207

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sterling Capital Management's STLN Position: Q2 2026 in Review

Sterling Capital Management increased its Starling Oncology (STLN) stake by 9.5% in Q2 2026, buying an estimated $206 and bringing the position to 567 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Sterling Capital Management first reported a position in STLN in Q2 2025 and has held it in 5 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Sterling Capital Management held 567 shares of Starling Oncology worth $3.08K as of Q2 2026.
  • Sterling Capital Management bought 49 Starling Oncology shares in Q2 2026, an estimated $206.
  • Starling Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2860 holding.
  • Sterling Capital Management first reported a position in Starling Oncology in Q2 2025 and has held it in 5 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.